- Home
- MKZR vs BGLC Comparison
MKZR vs BGLC Comparison
Compare MKZR & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MKZR | BGLC |
|---|---|---|
| Founded | 2012 | 2017 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6M | 4.3M |
| IPO Year | 2012 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MKZR | BGLC |
|---|---|---|
| Price | $1.47 | $1.61 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 11.7K | 9.4K |
| Earning Date | 05-14-2026 | 04-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.78 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $22,059,843.00 | $7,424,911.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 40.19 | N/A |
| 52 Week Low | $0.83 | $1.07 |
| 52 Week High | $6.99 | $6.10 |
Technical Indicators
Market Signals| Indicator | MKZR | BGLC |
|---|---|---|
| Relative Strength Index (RSI) | 45.33 | 42.89 |
| Support Level | $1.37 | $1.23 |
| Resistance Level | $1.84 | $1.88 |
| Average True Range (ATR) | 0.06 | 0.12 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 44.44 | 32.81 |
Price Performance
Historical ComparisonAbout MKZR MacKenzie Realty Capital Inc.
Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate. It is a real estate investment manager who utilizes an approach to real estate securities, often seeing opportunities that others overlook. Based in Orinda, California, MacKenzie Capital Management has specialized in discounted real estate securities and asset management.
About BGLC BioNexus Gene Lab Corp
BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.